↓ Skip to main content

Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, May 1995
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent
21 patents

Citations

dimensions_citation
49 Dimensions

Readers on

mendeley
25 Mendeley
Title
Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer
Published in
Cancer Chemotherapy and Pharmacology, May 1995
DOI 10.1007/bf00688325
Pubmed ID
Authors

Karen Hoffman, Frankie Ann Holmes, Giuseppe Fraschini, Laura Esparza, Debra Frye, Martin N. Raber, Robert A. Newman, Gabriel N. Hortobagyi

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 24%
Student > Ph. D. Student 5 20%
Student > Doctoral Student 3 12%
Student > Bachelor 2 8%
Student > Postgraduate 2 8%
Other 4 16%
Unknown 3 12%
Readers by discipline Count As %
Medicine and Dentistry 11 44%
Biochemistry, Genetics and Molecular Biology 4 16%
Agricultural and Biological Sciences 3 12%
Psychology 2 8%
Computer Science 1 4%
Other 1 4%
Unknown 3 12%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2017.
All research outputs
#5,446,994
of 25,374,917 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#272
of 2,561 outputs
Outputs of similar age
#3,244
of 23,413 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#1
of 9 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,561 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 23,413 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them